>> Effective vaccines are likely to be combined with other immunostimulatory approaches including adoptive T cell therapies and to be deployed in postsurgical a

>> Effective vaccines are likely to be combined with other immunostimulatory approaches including adoptive T cell therapies and to be deployed in postsurgical adjuvant settings to prevent relapses. Mostly post-surgical, but I wouldn't be surprised if eventually used for metastatic as well. Good luck to all involved.